In an expansive sea of expensive newsletters, it can be easy to not know which to read or how to pay. Thankfully there is an option that offers both quality information about Oncology and which is absolutely free online. Oncotarget is co-edited by noted Roswell Park Cancer Institute researcher Mikhail Blagosklonny and his peer Andrei V. Gudkov. With their help, Oncotarget supplies finest Oncology research straight to your web browser!
Oncotarget has had a citation impact of 5.0008 both in 2015 and 2016 and is among the most well-regarded journals existing in the current state of the Oncology market. It has received numerous rewards alongside the recognition that puts it a cut above both free and subscription-based Oncology Journals.
Oncotarget focuses not only on Oncology but also on Mikhail Blagosklonny’s research specialties Mikhail Blagosklonny is a seasoned research on both cancer and other leading causes of premature death. He is a staunch advocate for expanding the use of the Cancer drug Rapamycin to treat a variety ailments, with a focus to increase life expectancy at an affordable cost for all. To reflect this interest a variety of fields are covered by Oncotargert, fields from Cardiology to Metabolism have a prominent place in the journal, spreading information about good health and long life far and beyond the central cancer topic. So why wait!? Oncotarget is available anywhere there is a web connection and is absolutely free to use to check up on all the current research and news in the Oncology field. Read today!